Free Trial

EDAP TMS (NASDAQ:EDAP) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?

Edap Tms logo with Medical background

Key Points

  • Edap Tms S.A. shares have surpassed their 200-day moving average, trading as high as $2.70, with the last recorded price at $2.61.
  • Research firms have recently adjusted their ratings, with Piper Sandler downgrading Edap Tms from "overweight" to "neutral" and an overall average rating of "Hold" with a target price of $8.50.
  • Institutional investors now hold 62.74% of Edap Tms stock, with several firms significantly increasing their positions in recent quarters.
  • MarketBeat previews the top five stocks to own by November 1st.

Shares of EDAP TMS S.A. (NASDAQ:EDAP - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.84 and traded as high as $2.70. EDAP TMS shares last traded at $2.61, with a volume of 31,623 shares changing hands.

EDAP TMS Stock Performance

The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.05 and a current ratio of 1.51. The stock has a market cap of $87.87 million, a price-to-earnings ratio of -3.85 and a beta of -0.21. The firm's 50-day moving average price is $1.72 and its two-hundred day moving average price is $1.83.

Hedge Funds Weigh In On EDAP TMS

Several large investors have recently modified their holdings of EDAP. Cetera Investment Advisers lifted its position in shares of EDAP TMS by 33.9% during the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock worth $147,000 after purchasing an additional 19,000 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in EDAP TMS by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after buying an additional 25,650 shares in the last quarter. Simplicity Wealth LLC acquired a new stake in EDAP TMS during the 2nd quarter worth approximately $54,000. Millennium Management LLC raised its stake in shares of EDAP TMS by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock valued at $108,000 after acquiring an additional 33,558 shares in the last quarter. Finally, Jane Street Group LLC raised its stake in shares of EDAP TMS by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73,361 shares in the last quarter. Institutional investors and hedge funds own 62.74% of the company's stock.

EDAP TMS Company Profile

(Get Free Report)

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

Featured Stories

Should You Invest $1,000 in Edap Tms Right Now?

Before you consider Edap Tms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.

While Edap Tms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.